Biobanking Market to Reach $36.8 Billion by 2024
- Published: July 2019
The global biobanking market is expected to generate $36.8 billion revenue by 2024, advancing at a CAGR of 6.2%, during the forecast period. Factors, such as increasing need for cost-effective drug discovery, and rising demand for cell lines, directly pose a positive impact on the market growth, according to P&S Intelligence.
Insights into Market Segments
Based on offering, the biobanking market is classified into consumables, equipment, services, and software. Of these, the consumables category is expected to lead the market in the coming years. Further, the market in the software category is predicted to advance at a CAGR of 5.4%, during the forecast period.
The consumables category is further bifurcated into storage, analysis, processing, and collection. Out of all the consumables, the consumables utilized for storage is expected to dominate the overall biobanking market in the future, mainly due to the increasing number of blood products, tissues, and cell lines being preserved in the biobanks.
The biobanking market is categorized into blood products and genetic materials, human tissues, cell lines, biological fluids, and human waste products, based on the type of sample. Amongst these, the blood products and genetic material category is expected to hold the largest revenue share during the forecast period, with a contribution of 42.1% by 2024 in the global market. Dur to the rising prevalence of chronic diseases, it is expected that preservation of blood products such as plasma, serum, and platelets would be on rise in the coming future.
Asia-Pacific (APAC) Biobanking Market to Observe the Highest Growth in the Coming Years
The biobanking market in APAC is expected to witness lucrative growth as a consequence of increasing awareness about biobanking in the region, witnessing a CAGR of 6.8% during the forecast period. Growing population, and increasing clinical research are the other factors that positively impact the growth of the market in this region.
Further, due to the growing research activities, there is a wide scope for the growth of the biotechnology sector in this region. This growth is also likely to be supported by the large amount of funds that are received from various government and private sectors organizations. Presence of regional players also contribute to the growth of the market.
Browse report overview with 298 tables and 108 figures spread through 298 pages and detailed TOC on "Biobanking Market Research Report: By Offering (Consumables, Equipment, Services, Software), Sample Type (Blood Products and Genetic Material, Human Tissues, Cell Lines, Biological Fluids, Human Waste Products), Storage Type (Manual, Automated), Application (Clinical Research, Life Science and medical Research, Regenerative Medicine), Utility (Research, Routine, Epidemiology), Regional Insight (U.S. Canada, Germany, France, U.K., Italy, Spain, Japan, China, India, Brazil, Mexico, Saudi Arabia, South Africa, U.A.E.) – Industry Analysis and Forecast to 2024" at:https://www.psmarketresearch.com/market-analysis/biobanking-market
Biobanking Market Competitive Landscape
The biobanking market is fragmented in nature; Thermo Fisher Scientific Inc, Merck KGaA, Promega Corporation, Becton, Dickinson and Company, Hamilton Company, Avantor Inc., Tecan Group Ltd., QIAGEN N.V., PHC Holdings Corporation, Brooks Automation Inc., AutoGen Inc., BioCision, BioLife Solutions Inc. are some of the major players with a broad presence in this market.
In March 2019, Tecan Group Ltd. and QIAGEN N.V. announced a collaboration to improve the performance of QIAGEN’s QuantiFERON-TB Gold Plus (QFT-Plus) diagnostic test through the utilization of Tecan’s Fluent Laboratory Automation workstation for the aliquoting of samples for the optional Lithium Heparin single-tube workflow. The Fluent instruments will be supplied directly to laboratories through Tecan’s Life Sciences Business.
Similarly, in March 2019, Becton, Dickinson and Company launched automated flow cytometry sample preparation instrument with CE-IVD certification known as, BD FACSDuet. This instrument helps in understanding the characteristics of cell as well as counting.
BIOBANKING MARKET SEGMENTATION
Market Segmentation by Offering
- Consumables
- Equipment
- Services
- Software
Market Segmentation by Sample Type
- Blood Products and Genetic Material
- Human Tissues
- Cell Lines
- Biological Fluids
- Human Waste Products
Market Segmentation by Storage Type
- Manual
- Automated
Market Segmentation by Application
- Clinical Research
- Life Science and medical Research
- Regenerative Medicine
Market Segmentation by Utility
- Research
- Routine
- Epidemiology
Market Segmentation by Geography
-
North America Biobanking Market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
By country – U.S. and Canada
-
U.S. biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
Canada biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
U.S. biobanking market
-
Europe Biobanking Market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
By country – Germany, France, U.K., Italy, Spain, and Rest of Europe
-
Germany biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
Germany biobanking market
-
-
-
U.K. biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
U.K. biobanking market
-
-
-
-
France biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
Italy biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
Spain biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
France biobanking market
-
-
APAC Biobanking Market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
By country – Japan, China, India, and Rest of APAC
-
Japan biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
China biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
India biobanking market
- By offering
- By sample type
- By storage type
- By application
- By utility
-
Japan biobanking market
-
Latin America (LATAM) Biobanking Market
- By offering
- By sample type
- By storage type
- By application
- By utility
- By country – Brazil, Mexico, and Rest of LATAM
-
Middle East and Africa (MEA) Biobanking Market
- By offering
- By sample type
- By storage type
- By application
- By utility
- By country – Saudi Arabia, South Africa, U.A.E., and Rest of MEA